Amid talks of third wave of Coronavirus in India, the domestic stock market is expected to remain volatile and experts are suggesting investors to continue stock specific trade, keeping special focus on the pharmaceutical sector stocks.
Speaking on the shares to buy today Avinash Gorakshkar, Head of Research at Profitmart securities said, “Currently, the market looks unmoved by the rising Covid-19 cases in India but if you look at the FIIs trade practice in recent days, they are fishing out their money from the Indian markets.
Asked about the pharma stocks that one can look at, Gorakshkar said that Lupin, Cipla and Divi’s Lab are some of the prominent shares that one can buy at current price keeping one to three month time-horizon.
On Cipla and Divi’s Lab shares Ravi Singhal of GCL Securities said that one can buy Cipla shares at current levels for the target of ₹1044 maintaining stop loss at ₹844.